These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18456253)

  • 1. Memantine does not show intracellular block of the NMDA receptor channel.
    Parsons CG; Gilling KE; Jatzke C
    Eur J Pharmacol; 2008 Jun; 587(1-3):99-103. PubMed ID: 18456253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.
    Gilling KE; Jatzke C; Hechenberger M; Parsons CG
    Neuropharmacology; 2009 Apr; 56(5):866-75. PubMed ID: 19371579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine.
    Gilling KE; Jatzke C; Parsons CG
    Neuropharmacology; 2007 Sep; 53(3):415-20. PubMed ID: 17632186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
    Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
    J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro galantamine-memantine co-application: mechanism of beneficial action.
    Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
    Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.
    Medvedev IO; Malyshkin AA; Belozertseva IV; Sukhotina IA; Sevostianova NY; Aliev K; Zvartau EE; Parsons CG; Danysz W; Bespalov AY
    Neuropharmacology; 2004 Aug; 47(2):175-83. PubMed ID: 15223296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different capacities of various NMDA receptor antagonists to prevent ischemia-induced neurodegeneration in human cultured NT2 neurons.
    Garcia de Arriba S; Wegner F; Grüner K; Verdaguer E; Pallas M; Camins A; Wagner A; Wohlfahrt K; Allgaier C
    Neurochem Int; 2006 Oct; 49(5):466-74. PubMed ID: 16650914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonist properties of polyamines and bis(ethyl)polyamines at N-methyl-D-aspartate receptors.
    Igarashi K; Williams K
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1101-9. PubMed ID: 7891322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.
    Bresink I; Benke TA; Collett VJ; Seal AJ; Parsons CG; Henley JM; Collingridge GL
    Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mg2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes.
    Wrighton DC; Baker EJ; Chen PE; Wyllie DJ
    J Physiol; 2008 Jan; 586(1):211-25. PubMed ID: 17962329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking kinetics of memantine on NR1a/2A receptors recorded in inside-out and outside-out patches from Xenopus oocytes.
    Parsons CG; Gilling KE; Jatzke C
    J Neural Transm (Vienna); 2008 Oct; 115(10):1367-73. PubMed ID: 18607526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo.
    Masuko T; Suzuki T; Miyake M; Kusama-Eguchi K; Kizawa Y; Tomono K; Kashiwagi K; Igarashi K; Kusama T
    Neurosci Lett; 2012 Jan; 506(2):251-5. PubMed ID: 22119002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels.
    Chen HS; Lipton SA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):961-71. PubMed ID: 15901795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in degree of trapping of low-affinity uncompetitive N-methyl-D-aspartic acid receptor antagonists with similar kinetics of block.
    Mealing GA; Lanthorn TH; Murray CL; Small DL; Morley P
    J Pharmacol Exp Ther; 1999 Jan; 288(1):204-10. PubMed ID: 9862772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor.
    Masuko T; Nagaoka H; Miyake M; Metori K; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
    Neurochem Int; 2007 Jan; 50(2):443-9. PubMed ID: 17113196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine as an example of a fast, voltage-dependent, open channel N-methyl-D-aspartate receptor blocker.
    Parsons CG; Gilling K
    Methods Mol Biol; 2007; 403():15-36. PubMed ID: 18827985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors.
    Maskell PD; Speder P; Newberry NR; Bermudez I
    Br J Pharmacol; 2003 Dec; 140(7):1313-9. PubMed ID: 14645141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the alpha9alpha10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-D-aspartate receptors.
    Plazas PV; Savino J; Kracun S; Gomez-Casati ME; Katz E; Parsons CG; Millar NS; Elgoyhen AB
    Eur J Pharmacol; 2007 Jul; 566(1-3):11-9. PubMed ID: 17466293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity.
    Volbracht C; van Beek J; Zhu C; Blomgren K; Leist M
    Eur J Neurosci; 2006 May; 23(10):2611-22. PubMed ID: 16817864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors.
    Kloda A; Clements JD; Lewis RJ; Adams DJ
    Mol Pharmacol; 2004 Jun; 65(6):1386-96. PubMed ID: 15155832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.